BioGaia AB

BioGaia AB is a pioneering company in probiotic innovation, committed to advancing digestive and immune health worldwide. Founded over three decades ago by Peter Rothschild and Jan Annwall, the company began with the discovery of Limosilactobacillus reuteri, a probiotic strain that became the cornerstone of their research. Supported by hundreds of clinical studies and available in over 100 countries, BioGaia develops safe, effective, and scientifically validated products for all ages. With a focus on innovation, integrity, and accessibility, the brand empowers individuals to support gut, immune, and oral health confidently, making probiotic wellness simple, reliable, and evidence-based.